FDA Approved: COMBIGAN — Original Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved COMBIGAN, a fixed-dose combination eye drop of brimonidine tartrate and timolol maleate, under Allergan's original NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Combigan (brimonidine tartrate and timolol maleate)

Snippet

ORIG AP for COMBIGAN (BRIMONIDINE TARTRATE, TIMOLOL MALEATE)